A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients

Translated title of the contribution: A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients

I.E.L.M. Kuppens, E.O. Witteveen, R.C. Jewell, S.A Radema, E.M. Paul, S.G. Mangum, J.H. Beijnen, E.E. Voest, J.H.M. Schellens

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionA phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients
Original languageUndefined/Unknown
Pages (from-to)3276-3285
Number of pages10
JournalClinical Cancer Research
Volume13
Issue number11
Publication statusPublished - 2007

Cite this